(NASDAQ: APLT) Applied Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Applied Therapeutics's revenue in 2024 is -$477,000.On average, 1 Wall Street analysts forecast APLT's revenue for 2024 to be $1,965,398,970, with the lowest APLT revenue forecast at $1,965,398,970, and the highest APLT revenue forecast at $1,965,398,970. On average, 1 Wall Street analysts forecast APLT's revenue for 2025 to be $8,295,811,933, with the lowest APLT revenue forecast at $8,295,811,933, and the highest APLT revenue forecast at $8,295,811,933.
In 2026, APLT is forecast to generate $9,438,485,753 in revenue, with the lowest revenue forecast at $9,438,485,753 and the highest revenue forecast at $9,438,485,753.